Sep 14, 2026 · 39 min
Amino acids may offer a cheaper route to glutathione
Your Body Makes Its Own Master Antioxidant — Here's Why It Stops.
The episode frames declining glutathione as an age-related source of oxidative stress and examines whether targeted nutrition can support its production.
- 1Glutathione tends to decline with age, potentially leaving cells more vulnerable to oxidative stress.
- 2Raising glutathione may require supporting the body’s production systems rather than relying on supplements or IV treatments alone.
- 3Research on glycine and N-acetylcysteine points to a lower-cost nutritional approach for rebuilding glutathione.
Don't miss
Josh Axe’s central argument is that glycine and N-acetylcysteine may support glutathione production without making costly IV treatment the default.
The brief
Josh Axe opens with a challenge to the usual glutathione pitch: higher levels may depend less on buying a treatment and more on helping cells make their own supply.
The episode links aging with declining glutathione and greater oxidative stress, making the antioxidant’s loss a question of cellular resilience rather than a simple supplement gap.
Its central intervention is GlyNAC, a combination of glycine and N-acetylcysteine studied for supporting glutathione production and antioxidant capacity.
The standout idea is practical and economic: targeted amino acids could offer a way to address glutathione decline without treating expensive IV therapy as the only answer.